KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Assets (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Current Assets for 8 consecutive years, with $300.2 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 5.79% to $300.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300.2 million through Dec 2025, up 5.79% year-over-year, with the annual reading at $300.2 million for FY2025, 5.79% up from the prior year.
  • Current Assets hit $300.2 million in Q4 2025 for Adaptive Biotechnologies, up from $281.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $765.0 million in Q1 2021 to a low of $256.5 million in Q1 2025.
  • Historically, Current Assets has averaged $425.2 million across 5 years, with a median of $414.7 million in 2022.
  • Biggest five-year swings in Current Assets: tumbled 46.77% in 2021 and later soared 39.58% in 2022.
  • Year by year, Current Assets stood at $402.7 million in 2021, then skyrocketed by 39.58% to $562.1 million in 2022, then dropped by 27.03% to $410.2 million in 2023, then tumbled by 30.82% to $283.8 million in 2024, then increased by 5.79% to $300.2 million in 2025.
  • Business Quant data shows Current Assets for ADPT at $300.2 million in Q4 2025, $281.4 million in Q3 2025, and $261.9 million in Q2 2025.